KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
92 hedge funds and large institutions have $589M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 12 reducing their positions, and 13 closing their positions.
577% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $197K
300% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 12
77% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 13
30% more capital invested
Capital invested by funds: $453M → $589M (+$136M)
11% more funds holding
Funds holding: 83 → 92 (+9)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$29.9M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$24.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$23.6M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$19.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
-$10.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.95M |
| 3 |
IA
Investor AB
Stockholm,
Sweden
|
-$3.54M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.76M |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$912K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
SG Americas Securities
New York
| – | -$130K | -2,849 | Closed |
|
|
PA
102
Perceptive Advisors
New York
| – | -$126K | -2,765 | Closed |
|
|
PAM
103
Panagora Asset Management
Boston,
Massachusetts
| – | -$62K | -1,359 | Closed |
|
104
California Public Employees Retirement System
Sacramento,
California
| – | -$18K | -400 | Closed |
|
105
Creative Planning
Overland Park,
Kansas
| – | -$8K | -182 | Closed |
|
KYTH Hedge Fund Activity: Q4 2013 in Review
92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2013, worth a combined $589M — up 30% from $453M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new KYTH positions and 13 closed out — a net gain of 10 holders — while 48 added to existing stakes and 12 trimmed.
The largest buyer was Waddell & Reed Financial, adding an estimated $29.9M. The largest seller was Columbus Circle Investors, exiting entirely with an estimated $10.7M sold.
- 92 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2013, up from 83 in Q3 2013.
- Funds reported $589M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2013, up 30% quarter-over-quarter.
- 23 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2013 and 13 closed out, a net change of +10 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q4 2013 was Waddell & Reed Financial, an estimated $29.9M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2013 was Columbus Circle Investors, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2013.